Skip to main navigation Skip to search Skip to main content

Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to chemotherapy by abrogating the ToPBP1/ATR-mediated DNA damage response

  • Li Ding
  • , Vijay S. Madamsetty
  • , Spencer Kiers
  • , Olga Alekhina
  • , Andrey Ugolkov
  • , John Dube
  • , Yu Zhang
  • , Jin San Zhang
  • , Enfeng Wang
  • , Shamit K. Dutta
  • , Daniel M. Schmitt
  • , Francis J. Giles
  • , Alan P. Kozikowski
  • , Andrew P. Mazar
  • , Debabrata Mukhopadhyay
  • , Daniel D. Billadeau

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to chemotherapy by abrogating the ToPBP1/ATR-mediated DNA damage response'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology